Literature DB >> 23553701

Economic evaluation of the anti-stigma social marketing campaign in England 2009-2011.

Sara Evans-Lacko1, Claire Henderson, Graham Thornicroft, Paul McCrone.   

Abstract

BACKGROUND: Evidence on the economic impact of social marketing anti-stigma campaigns in relation to people with mental illness is limited. AIMS: To describe the economic impact of the Time to Change (TTC) anti-stigma social marketing campaign, including the potential effects on the wider economy.
METHOD: Data collected for the evaluation of TTC were combined with the social marketing campaign expenditure data to investigate differences in knowledge, attitudes and behaviour in relation to campaign awareness. To evaluate the return on investment, we applied a decision model that estimated the impact on employment for people with depression.
RESULTS: Based on average national social marketing campaign costs, the economic benefits outweighed costs even if the campaign resulted in only 1% more people with depression accessing services and gaining employment if they experienced a health improvement. The cost per person with improved intended behaviour was at most £ 4 if we assume the campaign was responsible for 50% of the change. Costs associated with improved knowledge and attitudes, however, were more variable.
CONCLUSIONS: The findings suggest that the TTC anti-stigma social marketing campaign is a potentially cost-effective and low-cost intervention for reducing the impact of stigma on people with mental health problems.

Entities:  

Mesh:

Year:  2013        PMID: 23553701     DOI: 10.1192/bjp.bp.112.113746

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  8 in total

1.  With Small Power, Comes Great Responsibility: Lessons Learned from an Evaluation of Veteran and Military Mental Health Public Awareness Campaigns.

Authors:  Joie D Acosta; J Scott Ashwood; Terry L Schell; Jennifer L Cerully
Journal:  Community Ment Health J       Date:  2019-07-02

2.  Investment in Social Marketing Campaign to Reduce Stigma and Discrimination Associated with Mental Illness Yields Positive Economic Benefits to California.

Authors:  J Scott Ashwood; Brian Briscombe; Rebecca L Collins; Eunice C Wong; Nicole K Eberhart; Jennifer Cerully; Libby May; Beth Roth; M Audrey Burnam
Journal:  Rand Health Q       Date:  2017-01-13

3.  Community mental health care worldwide: current status and further developments.

Authors:  Graham Thornicroft; Tanya Deb; Claire Henderson
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

4.  How much does mental health discrimination cost: valuing experienced discrimination in relation to healthcare care costs and community participation.

Authors:  S Evans-Lacko; S Clement; E Corker; E Brohan; L Dockery; S Farrelly; S Hamilton; V Pinfold; D Rose; C Henderson; G Thornicroft; P McCrone
Journal:  Epidemiol Psychiatr Sci       Date:  2014-06-06       Impact factor: 6.892

Review 5.  Return on investment of public health interventions: a systematic review.

Authors:  Rebecca Masters; Elspeth Anwar; Brendan Collins; Richard Cookson; Simon Capewell
Journal:  J Epidemiol Community Health       Date:  2017-03-29       Impact factor: 3.710

Review 6.  Promotion, prevention and protection: interventions at the population- and community-levels for mental, neurological and substance use disorders in low- and middle-income countries.

Authors:  Inge Petersen; Sara Evans-Lacko; Maya Semrau; Margaret M Barry; Dan Chisholm; Petra Gronholm; Catherine O Egbe; Graham Thornicroft
Journal:  Int J Ment Health Syst       Date:  2016-04-11

Review 7.  The effectiveness of interventions targeting the stigma of mental illness at the workplace: a systematic review.

Authors:  Sabine E Hanisch; Conal D Twomey; Andrew C H Szeto; Ulrich W Birner; Dennis Nowak; Carla Sabariego
Journal:  BMC Psychiatry       Date:  2016-01-06       Impact factor: 3.630

8.  Public knowledge, attitudes, social distance and reported contact regarding people with mental illness 2009-2015.

Authors:  C Henderson; E Robinson; S Evans-Lacko; E Corker; I Rebollo-Mesa; D Rose; G Thornicroft
Journal:  Acta Psychiatr Scand       Date:  2016-08       Impact factor: 6.392

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.